ILA 39980.0
(0.63%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 1.32 Billion | 640 Million | 1.23 Billion | 613 Million | 695 Million | 1.14 Billion |
Net Income | -5 Million | 298 Million | 223 Million | -366 Million | -262 Million | 404 Million |
Depreciation & Amortization | 479 Million | 689 Million | 599 Million | 603 Million | 582 Million | 372 Million |
Deferred income taxes | 917 Million | 275 Million | -102 Million | 224 Million | 460 Million | -1 Million |
Stock-based compensation | 7 Million | 12 Million | 8 Million | 3 Million | 5 Million | 6 Million |
Change in working capital | -375 Million | -947 Million | 317 Million | 68 Million | -217 Million | 143 Million |
Other non-cash items | 305 Million | 313 Million | 189 Million | 81 Million | 127 Million | 224 Million |
Investing Cash Flow | -590 Million | -2.18 Billion | -491 Million | -267 Million | 2.61 Billion | -796 Million |
Investments in PPE | -374 Million | -648 Million | -354 Million | -250 Million | -313 Million | -372 Million |
Acquisitions | -273 Million | -1.57 Billion | -239 Million | -35 Million | - | - |
Investment purchases | - | - | 78 Million | - | - | - |
Sales/Maturities of investments | - | - | 17 Million | - | 2.9 Billion | 147 Million |
Other Investing Activities | 57 Million | 41 Million | 7 Million | 18 Million | 23 Million | -571 Million |
Financing Cash Flow | -1.28 Billion | 464 Million | 405 Million | -226 Million | -3.25 Billion | 35 Million |
Debt repayment | -1.59 Billion | -643 Million | -217 Million | -1.08 Billion | -3.15 Billion | -578 Million |
Dividends payments | - | - | - | -60 Million | -280 Million | -400 Million |
Common Stock Repurchased | - | - | - | -200 Million | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 311 Million | 1.1 Billion | 622 Million | 1.11 Billion | 177 Million | -143 Million |
Accounts receivables | -87 Million | -536 Million | -319 Million | 297 Million | 47 Million | -21 Million |
Accounts payables | 87 Million | 536 Million | 319 Million | -297 Million | -47 Million | - |
Inventory | -151 Million | -549 Million | -168 Million | 214 Million | -25 Million | 21 Million |
Other working capital | -224 Million | -398 Million | 485 Million | -146 Million | -192 Million | 122 Million |
Cash at beginning of period | 1.53 Billion | 2.67 Billion | 1.5 Billion | 1.38 Billion | 1.36 Billion | 1.04 Billion |
Cash at end of period | 1.09 Billion | 1.53 Billion | 2.67 Billion | 1.5 Billion | 1.38 Billion | 1.36 Billion |
Capital Expenditure | -374 Million | -648 Million | -354 Million | -250 Million | -313 Million | -372 Million |
Effect of forex changes on cash | 109 Million | 43 Million | 25 Million | -3 Million | -31 Million | -65 Million |
Net cash flow / Change in cash | -440 Million | -1.14 Billion | 1.17 Billion | 117 Million | 24 Million | 322 Million |
Free Cash Flow | 954 Million | -8 Million | 880 Million | 363 Million | 382 Million | 776 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 248 Million | 200 Million | -5 Million | 63 Million | -238 Million | 85 Million |
Depreciation & Amortization | 124 Million | 121 Million | 479 Million | -354 Million | 259 Million | 116 Million |
Deferred income taxes | - | - | 917 Million | 428 Million | 382 Million | 101 Million |
Stock-based compensation | 2 Million | 1 Million | 7 Million | 1 Million | 1 Million | 3 Million |
Change in working capital | 14 Million | 118 Million | -375 Million | -204 Million | -282 Million | 72 Million |
Other non-cash items | 60 Million | -71 Million | 305 Million | 34 Million | 78 Million | 100 Million |
Investing Cash Flow | 250 Million | 69 Million | -590 Million | -118 Million | -269 Million | -67 Million |
Investments in PPE | -44 Million | -50 Million | -374 Million | -72 Million | -91 Million | -82 Million |
Acquisitions | 273 Million | -1 Million | -273 Million | -112 Million | -160 Million | - |
Investment purchases | -1 Million | - | - | - | -27 Million | - |
Sales/Maturities of investments | - | - | - | - | 4 Million | - |
Other Investing Activities | 285 Million | 100 Million | 57 Million | 66 Million | 5 Million | 15 Million |
Financing Cash Flow | -900 Million | -177 Million | -1.28 Billion | 131 Million | -349 Million | -330 Million |
Debt repayment | -696 Million | -1 Million | -1.59 Billion | -244 Million | -62 Million | -179 Million |
Dividends payments | -75 Million | -75 Million | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -60 Million | -1 Million | 311 Million | 375 Million | -349 Million | -151 Million |
Accounts receivables | 9 Million | -50 Million | -87 Million | 230 Million | -465 Million | 117 Million |
Accounts payables | - | - | 87 Million | -230 Million | 465 Million | -117 Million |
Inventory | 25 Million | 145 Million | -151 Million | -92 Million | -177 Million | 89 Million |
Other working capital | 2 Million | -2 Million | -224 Million | -112 Million | -105 Million | -17 Million |
Cash at beginning of period | 1.36 Billion | 1.09 Billion | 1.53 Billion | 1.11 Billion | 1.23 Billion | 1.15 Billion |
Cash at end of period | 1.02 Billion | 1.36 Billion | 1.09 Billion | 1.09 Billion | 1.11 Billion | 1.23 Billion |
Capital Expenditure | -44 Million | -50 Million | -374 Million | -72 Million | -91 Million | -82 Million |
Effect of forex changes on cash | - | - | 109 Million | - | -4 Million | -1 Million |
Net cash flow / Change in cash | -336 Million | 268 Million | -440 Million | -19 Million | -119 Million | 81 Million |
Free Cash Flow | 255 Million | 341 Million | 954 Million | -104 Million | 109 Million | 395 Million |
KALYANCAP
BIOL
1072
ACTIVE
EQTRF
9435